TScan Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2021 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
TScan Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2023.
  • TScan Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.25 USD/shares, a 4.17% decline year-over-year.
  • TScan Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.53 USD/shares, a 78.5% increase year-over-year.
  • TScan Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.36 USD/shares, a 50.5% increase from 2022.
  • TScan Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.75 USD/shares, a 34.1% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 +$1.39 +50.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 -$3 +$1.42 +34.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 -$4 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.